Cresco Labs Inc. (OTCMKTS:CRLBF - Free Report) - Ventum Cap Mkts lowered their FY2024 earnings per share estimates for Cresco Labs in a research note issued on Monday, November 11th. Ventum Cap Mkts analyst A. Semple now expects that the company will earn ($0.17) per share for the year, down from their previous estimate of ($0.16). Ventum Cap Mkts has a "Strong-Buy" rating on the stock. The consensus estimate for Cresco Labs' current full-year earnings is ($0.19) per share. Ventum Cap Mkts also issued estimates for Cresco Labs' FY2025 earnings at ($0.08) EPS.
Other research analysts have also recently issued reports about the company. Needham & Company LLC reaffirmed a "hold" rating on shares of Cresco Labs in a research report on Monday, August 12th. Roth Capital raised shares of Cresco Labs to a "strong-buy" rating in a report on Sunday. Finally, Cormark cut shares of Cresco Labs from a "moderate buy" rating to a "hold" rating in a report on Monday. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $2.50.
Get Our Latest Analysis on Cresco Labs
Cresco Labs Stock Up 14.3 %
Shares of OTCMKTS CRLBF traded up $0.18 during mid-day trading on Thursday, hitting $1.44. The company had a trading volume of 919,928 shares, compared to its average volume of 752,714. Cresco Labs has a 1-year low of $1.02 and a 1-year high of $2.65. The company has a market capitalization of $702.92 million, a PE ratio of -7.20 and a beta of 1.88. The company has a debt-to-equity ratio of 1.76, a current ratio of 2.00 and a quick ratio of 1.30. The business's 50-day simple moving average is $1.58 and its 200 day simple moving average is $1.70.
About Cresco Labs
(
Get Free Report)
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
See Also
Before you consider Cresco Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.
While Cresco Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.